Progresses in treating agitation: a major clinical challenge in Alzheimer's disease
B. Imbimbo
Expert opinion on pharmacotherapy, 2015
View PDFchevron_right
A Framework for Developing Pharmacotherapy for Agitation in Alzheimer’s Disease: Recommendations of the Isctm* Working Group
Hans J Moebius
The Journal of Prevention of Alzheimer's Disease, 2020
View PDFchevron_right
Managing agitation in Alzheimer's disease and related disorders
Linda Hershey MD, PhD FAAN FANA
View PDFchevron_right
Alternative pharmacological treatment options for agitation in Alzheimer’s disease
B. Imbimbo
Geriatric Care, 2015
View PDFchevron_right
Progress in Treatment Development for Neuropsychiatric Symptoms in Alzheimer’s Disease: Focus on Agitation and Aggression. A Report from the Eu/Us/Ctad Task Force
Joao Siffert
JPAD, 2015
View PDFchevron_right
Management of agitation and aggression associated with Alzheimerʼs disease: controversies and possible solutions
Philippe Robert
Current Opinion in Psychiatry, 2009
View PDFchevron_right
Management of agitation and aggression associated with Alzheimer disease
George Grossberg
Nature Reviews Neurology, 2009
View PDFchevron_right
Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions
anna digiovanni
Frontiers in Neurology, 2021
View PDFchevron_right
Pharmacological Management of Agitation and Aggression in Alzheimer’s Disease: A Review of Current and Novel Treatments
Sarah A Chau
View PDFchevron_right
Treatment of agitation in dementia
Anton Porsteinsson
New directions for mental health services, 1997
View PDFchevron_right
Agitation in patients with dementia: a systematic review of epidemiology and association with severity and course
Ann Hartry
International Psychogeriatrics
View PDFchevron_right
Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design
Constantine Lyketsos
International psychogeriatrics / IPA, 2014
View PDFchevron_right
A preclinical screen to evaluate pharmacotherapies for the treatment of agitation in dementia
Deaglan Page
Behavioural Pharmacology, 2017
View PDFchevron_right
Non-pharmacological interventions for agitation in dementia: systematic review of randomised controlled trials
Cornelius Katona
The British Journal of Psychiatry, 2014
View PDFchevron_right
Investigating the safety and efficacy of nabilone for the treatment of agitation in patients with moderate-to-severe Alzheimer's disease: Study protocol for a cross-over randomized controlled trial
Sandra Black
Contemporary Clinical Trials Communications, 2019
View PDFchevron_right
Pharmacologic Treatment of Agitation and Apathy in Dementia
Shailaja Shah
2007
View PDFchevron_right
Identifying Better Outcome Measures to Improve Treatment of Agitation in Dementia: A Report from the EU/US/CTAD Task Force
Constantine Lyketsos
The Journal of Prevention of Alzheimer's Disease, 2018
View PDFchevron_right
Neurobiological alteration in agitation in Alzheimer's disease and possible interventions
Jagadeesh Rao
2024
View PDFchevron_right
Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta-analysis
Itthipol Tawankanjanachot
British journal of clinical pharmacology, 2018
View PDFchevron_right
Nonpharmacological treatment of agitation: a controlled trial of systematic individualized intervention
Alexander Libin
The Journals …, 2007
View PDFchevron_right
Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial
Nimra Jamil
Alzheimer's & Dementia, 2019
View PDFchevron_right
Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease
Paula T Trzepacz
International Psychogeriatrics, 2012
View PDFchevron_right
Donepezil for the treatment of agitation in Alzheimer’s Disease
Dr Jude Hancock
View PDFchevron_right
Frequency of Behavioral Symptoms Characterizes Agitation In Alzheimer's Disease
Rochelle E Tractenberg
… journal of geriatric …, 2001
View PDFchevron_right
Nonpharmacological Management of Agitated Behaviours Associated with Dementia
Shelley Peacock
View PDFchevron_right
Nonpharmacological intervention for agitation in dementia: A systematic review and meta-analysis
eunhi kong
Aging & Mental Health, 2009
View PDFchevron_right
Principal components analysis of agitation outcomes in Alzheimer's disease
Lisa Kinoshita
Journal of psychiatric research, 2016
View PDFchevron_right
Treatment of agitation in AD: a randomized, placebo-controlled clinical trial.
Rochelle E Tractenberg
View PDFchevron_right
Citalopram for agitation in Alzheimer’s disease: Design and methods
Bruce Pollock
Alzheimer's & Dementia, 2012
View PDFchevron_right